Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.0600 (-0.37%) ($32.0600 - $32.0600) on Mon. Apr. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.98% (three month average) | RSI | 39 | Latest Price | $32.0600(-0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(41%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.99% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.99% (StdDev 3.98%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $31.05(3.25%) | 10 Day Moving Average | $30.78(4.16%) | 20 Day Moving Average | $32.01(0.16%) | To recent high | -39.1% | To recent low | 11.9% | Market Cap | $4.695b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |